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CORRESPONDENCE
Vaginal deliveries – is there a need for 
documented consent?
To the Editor: We thank Anthony et al.1 for responding to our article,2 
which was not meant to be prescriptive but to prompt thought, 
initiate discussion and exchange ideas about the issues raised. We feel 
we have been successful in raising interesting points that need to be 
considered. We do not intend responding to every point but highlight 
some essentials that were missed in their commentary.
Our central tenet is that vaginal delivery is not without its risks, 
and these hazards may include concerns about intrapartum care 
and non-medical risks with potential for medical complications. 
As we perceive these risks as ‘material’, we argue that they warrant 
discussion with the patient and that it would be prudent to document 
the conversation. This view is not inconsistent with the law, the 
regulator or ethics. Obtaining informed consent for a vaginal delivery 
does not equate to us favouring caesarean section over vaginal 
delivery, and we do not recommend that people in training should 
be taught this.
We feel that a weak justification is given as to why our legal 
arguments do not merit discussion. Medical practice is already 
regulated by laws that govern the conduct of business either directly 
or indirectly, The Medical Schemes Act (131 of 1998), Health 
Professions Act (56 of 1974) which has sections dealing with fees, 
and The National Health Act (61 of 2003), which also requires a 
health professional to disclose cost of treatment and management 
in Section 6 on informed consent. Private practitioners expect that 
reasonable fees will be paid to them by the patient for appropriate 
services rendered. This is legal and, where the fees are reasonable, 
not unethical. Doctors do not lose their professional ethical standards 
because of charges for services rendered. Public sector professionals 
are paid a global salary for services rendered. Business ethics exist 
alongside the doctor’s professional ethics and, should the ethical 
component of either be lost, it is common knowledge that the Health 
Professions Council can and does punish that person for unethical 
and unprofessional conduct.
Our paper is not an attack on the public sector nor does it attempt 
to create an obligation on the State to provide resources for all women 
to deliver by caesarean section. If anything, the resulting discourse as 
pertaining to the State should focus on its obligation to provide an 
environment that allows for safe vaginal deliveries and well-informed 
patients. We agree with Anthony et al. that, where a choice exists, this 
does not mean that a choice can be made. However, we do not agree 
that, based on this argument, women should not be given all material 
information and neither do we agree that the ‘therapeutic privilege’ 
should be invoked to justify this approach which, in our opinion, 
dangerously borders on paternalism.
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Decriminalisation of drugs
To the Editor: The progressive opinion expressed in your February 
editorial1 in the traditionally conservative SAMJ is to be lauded. 
The decriminalisation of drugs debate is usually such a political hot 
potato that no one wants to touch it. However, the war on drug users 
remains one of society’s long-standing civil wars, now being played 
out on an international stage in Afghanistan, where the quibble is 
largely over who controls the world’s opium supply, 92% of which 
comes from the poppy fields of that country.2
My work in the field of substance dependence treatment for the 
past 20 years has convinced me that declaring drugs illegal does not 
in the slightest act as a deterrent for the 10% of drug-dependent users 
who cause 90% of the drug-related problems. Many problems arising 
from drug use result from the fact that the substances are illegal, and 
not from the drugs themselves. Even the very act of being a non-
problematic drug user is in itself a criminal event.
The big fear most people harbour is that decriminalising, regulating 
or even legalising drugs will increase the prevalence of substance use 
behaviour. While this might be true to an extent, the perception that 
liberalisation will overwhelm and result in a nation of drug users is 
unfounded. 
The legalisation of commercial gambling in South Africa in 1996 
provides useful empirical evidence. Similarly the fear then was that 
legalisation of this previously prohibited industry would create a 
nation of problem gamblers. Yet prevalence studies3 show that the 
incidence of problem gambling in this country has not increased 
since its legalisation, despite the dramatic increase in the commercial 
size of the industry.
The likely increase in the prevalence of substance use that will 
result from decriminalisation of the activity must be carefully 
weighed against an inevitable decrease in the massive worldwide 
morbidity and mortality that currently arises from an illegal industry. 
Prohibition of drugs simply creates an underground economy that 
cannot be taxed, controlled or regulated. It causes corruption and fills 
the prisons with people found guilty of a victimless crime. It creates 
extremely lucrative monopolies for those prepared to take the risk, 
but does very little to deter those intent on drug use, which was the 
purpose of the prohibition.
Professor Hamid Ghodse, professor of psychiatry and drug policy 
and several times head of the International Narcotics Control Board 
and a long-standing drug war warrior, recently stated: ‘Legalization 
arguments don’t withstand critical evaluation and run contrary 
to general expectations. Proponents have yet to produce viable 
proposals. Liberalisation would irrevocably impact public health, 
social well-being and international stability.’4 Our challenge is to 
manage the problems arising from liberalisation of drug laws rather 
than bury our heads deeper in the sand, believing that we can legislate 
the problem away.
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